Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now presents a unified 'Locations' section with expanded site listings across the US, Canada, and Korea (California, District of Columbia, Florida, Kansas, Maryland, Michigan, Minnesota, New York, North Carolina, Oregon, Pennsylvania, Texas, Utah, Alberta, Ontario, Quebec, Gyeonggi-do), replacing prior separate location blocks. The HHS Vulnerability Disclosure link has been removed.SummaryDifference0.8%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed. A new revision label, v3.3.2, appears.SummaryDifference0.0%

- Check48 days agoChange DetectedThe general government funding status notice at the top of the ClinicalTrials.gov page was removed. This change does not affect study details, eligibility criteria, locations, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedTainan City, Taiwan was removed and Tainan, Taiwan added in the Locations section.SummaryDifference0.0%

- Check62 days agoChange DetectedThe new screenshot shows minor visual/layout adjustments with no changes to the main study details such as eligibility, interventions, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedPage metadata updated: newer dates and larger size added; older update markers and smaller size removed. Overall, this indicates a refresh of timing/size metadata rather than core content additions.SummaryDifference0.7%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.